Antimicrobial Agents and Chemotherapy · 2014 · 39 citations · 41 references
Several viruses, including human papillomaviruses, depend on endosomal acidification for successful infection. Hence, the multisubunit enzyme vacuolar ATPase (V-ATPase), which is mainly responsible for endosome acidification in the cell, represents an attractive target for antiviral strategies. In the present study, we show that V-ATPase is required for human papillomavirus (HPV) infection and that uncoating/disassembly but not endocytosis is affected by V-ATPase inhibition. The infection inhibitory potencies of saliphenylhalamide, a proven V-ATPase inhibitor, and its derivatives, as well as those of other V-ATPase inhibitors, were analyzed on different HPV types in relevant cell lines. Variation in the selectivity indices among V-ATPase inhibitors was high, while variation for the same inhibitor against different HPV subtypes was low, indicating that broad-spectrum anti-HPV activity can be provided.
41
Luisa L. Villa, Ronaldo Lúcio Rangel Costa, Carlos Alberto Petta et al. · The Lancet Oncology · 2005 · 1.6K citations
Jorma Paavonen, David Jenkins, F. Xavier Bosch et al. · The Lancet · 2007 · 1.3K citations
Worldwide burden of cervical cancer in 2008
Marc Arbyn, Xavier Castellsagué, Silvia de Sanjosé et al. · Annals of Oncology · 2011 · 1.1K citations
Worldwide Burden, Cervical Cancer Screening, Cervical Cancer Management +12
Carcinogenicity of human papillomaviruses
Vincent Cogliano, Robert A. Baan, Kurt Straíf et al. · The Lancet Oncology · 2005 · 692 citations
Cervical Cancer, Precancerous Lesions, Human Papillomavirus Vaccines +10